Depakote, Valproic Acid News

Find out more about Paul: Paul Bright is an aspiring psychotherapist who is currently working on his Masters in Counseling at Chapman University near the Bay Area.

A long-running study in the United Kingdom has shown for the first time that combined therapy with two of the main drugs for bipolar disorder is better than using either drug alone.

U.S. drug reviewers have recommended additional study of delayed development reported in children of mothers who took Abbott Laboratories' anti-seizure drug Depakote.

More Treatment News June 5, 2009 New Hope for HIV Eradication Researchers may finally be on track to get at the HIV that hides inside cells and keeps the infection going; if so, they could perhaps eradicate the virus from the body entirely, according to an article published in the July issue of Retrovirology .

Extended-Release Tablets as once-a-day add-on therapy for epilepsy patients 13 years of age or older with partial onset seizures.

The psychiatric mood stabilizer Depakote can significantly lower the average IQs of children whose mothers took the drug when they were pregnant, reported the New England Journal of Medicine on April 16, 2009.

Spina Bifida and seizures This week we'll start by describing a condition called spina bifida, a birth defect that involves incom-plete develop-ment of the spinal cord or its coverings.

GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal ODT Orally Disintegrating Tablets.

ROCKVILLE, Md., May 5, 2009--The FDA posted the following on its website about product labeling for antiepileptic drugs: Suicidal Behavior and Ideation and Antiepileptic Drugs Update 5/5/2009: AED class label changes Manufacturers of antiepileptic drugs or anticonvulsant drugs will update product labeling to include a warning about an increased ...

Abbott Laboratories markets Depakote ER for the treatment of epilepsy and bipolar disorders.

FDA also required development of a medication guide, to be issued to patients each time the product is dispensed.

Guidelines released this week recommend that women with epilepsy should avoid taking the anti-epilepsy drug valproate during pregnancy, because of the risk of harmful effects to the fetus.

Women with epilepsy should avoid taking the drug valproate during pregnancy if possible, according to new guidelines developed by the American Academy of Neurology and the American Epilepsy Society.

New guidelines out today provide some reassurance for the approximately half a million U.S. women of childbearing age who have epilepsy.

Despite recent concerns about fetal malformations linked to the anti-seizure medication valproate, most women with epilepsy can expect to have a relatively uneventful pregnancy with careful planning and preparation, say new guidelines from the American Academy of Neurology.

This week we'll start by describing a condition called spina bifida, a birth defect that involves incom-plete develop-ment of the spinal cord or its coverings.

Atypical Antipsychotic marketing contd. - A great interview with Professor David Healy by Christopher Lane Psychiatrist David Healy is the author of over 120 articles and 14 books, including Mania: A short history of Bipolar Disorder.

Children of mothers who took the epilepsy drug valproate during pregnancy had lower IQs than children of women who used other anti-seizure medicines, according to a new study.

Studies suggest that children of mothers who take Depakote during pregnancy have lower IQs than those of women taking some other anti-seizure drugs which are used as mood stabilizers in bipolar disorder.

Children born to women who took a popular epilepsy drug while pregnant had significantly lower I.Q. scores than those whose moms took a different drug, according to a new study.